Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Preferred Stock Liabilities (2019 - 2020)

Alx Oncology Holdings' Preferred Stock Liabilities history spans 2 years, with the latest figure at $175.0 million for Q2 2020.

  • For Q2 2020, Preferred Stock Liabilities rose 148.77% year-over-year to $175.0 million; the TTM value through Jun 2020 reached $175.0 million, up 148.77%, while the annual FY2019 figure was $70.4 million, 15.48% up from the prior year.
  • Preferred Stock Liabilities for Q2 2020 was $175.0 million at Alx Oncology Holdings, roughly flat from $175.0 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $175.0 million in Q1 2020 and bottomed at $70.4 million in Q2 2019.